Arbios Systems Presentation at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference to be Webcast Live
April 27 2005 - 3:16PM
PR Newswire (US)
Arbios Systems Presentation at Rodman & Renshaw Techvest 2nd
Annual Global Healthcare Conference to be Webcast Live LOS ANGELES,
April 27 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC:ABOS),
a biomedical device company developing proprietary liver assist
devices for the treatment of liver failure, today announced that
Amy Factor, Chief Executive Officer of Arbios Systems, will be
presenting at the Rodman & Renshaw Techvest 2nd Annual Global
Healthcare Conference on Wednesday, May 4, 2005 in Paris at 9:25am
local time (3:25am Eastern Time). The presentation will be webcast
live and can be accessed through the Company's website at
http://www.arbios.com/. An archive of the presentation will be
available for 90 days. About Arbios Arbios Systems, Inc. is a
biomedical device company that, through its wholly-owned
subsidiary, Arbios Technologies, Inc., is engaged in the discovery,
acquisition and development of proprietary liver assist devices and
new technologies useful in the diagnosis and treatment of acute
liver failure. Arbios' products in development include SEPET(TM), a
novel blood purification therapy and HepatAssist-2(TM), a
bioartificial liver combining liver cell therapy and sorbent-based
detoxification. DATASOURCE: Arbios Systems, Inc. CONTACT: Amy
Factor, Chief Executive Officer of Arbios Systems, Inc.,
+1-973-377-7665, ; or Paula Schwartz, investors, +1-917-322-2216,
or Pat Garrison, media, +1-917-322-2567, both of Rx Communications
Group Web site: http://www.arbios.com/
Copyright